| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.900 | limited | 0.865 | 4 | 0 | 2001 | 2019 | ||||||||
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.579 | 0.654 | 1.00 |
|
disease | 0.850 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
reelin | 0.515 | 0.731 | 1.00 |
|
disease | 0.700 | None | 0.909 | 4 | 0 | 1998 | 2020 | ||||||||
|
neurexin 1 | 0.581 | 0.692 | 1.00 |
|
disease | 0.700 | None | 0.932 | 3 | 0 | 2008 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.700 | None | 0.895 | 2 | 0 | 1992 | 2019 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.700 | None | 0.964 | 1 | 0 | 1995 | 2019 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.700 | None | 0.972 | 1 | 0 | 2000 | 2020 | ||||||||
|
SH3 and multiple ankyrin repeat domains 3 | 0.550 | 0.731 | 1.00 |
|
disease | 0.700 | None | 1.000 | 0 | 0 | 2010 | 2019 | ||||||||
|
reticulon 4 receptor | 0.595 | 0.692 | 0.96 |
|
disease | 0.670 | None | 0.857 | 0 | 0 | 2004 | 2017 | ||||||||
|
Sp4 transcription factor | 0.711 | 0.423 | 0.99 |
|
disease | 0.660 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
disease | 0.600 | None | 0.880 | 2 | 0 | 2003 | 2020 | ||||||||
|
DISC1 scaffold protein | 0.548 | 0.769 | 1.7E-06 |
|
disease | 0.600 | None | 0.947 | 2 | 0 | 2001 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.600 | None | 0.780 | 1 | 0 | 1995 | 2019 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.964 | 1 | 0 | 1993 | 2020 | ||||||||
|
neuregulin 3 | 0.670 | 0.615 | 0.11 |
|
disease | 0.600 | None | 0.786 | 1 | 0 | 2008 | 2020 | ||||||||
|
dystrobrevin binding protein 1 | 0.588 | 0.615 | 6.8E-06 |
|
disease | 0.600 | None | 0.948 | 1 | 0 | 2002 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.600 | None | 0.951 | 1 | 0 | 2000 | 2019 | ||||||||
|
complexin 2 | 0.736 | 0.231 | 0.53 |
|
disease | 0.580 | None | 1.000 | 2 | 0 | 1998 | 2015 | ||||||||
|
solute carrier family 6 member 1 | 0.592 | 0.538 | 1.00 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2001 | 2015 | ||||||||
|
phospholipase C beta 1 | 0.595 | 0.654 | 0.98 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.530 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
neuregulin 1 | 0.464 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.948 | 7 | 0 | 2002 | 2020 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.500 | None | 0.887 | 4 | 0 | 1984 | 2020 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.500 | None | 0.859 | 3 | 0 | 1997 | 2019 | ||||||||
|
phosphodiesterase 4B | 0.566 | 0.731 | 0.47 |
|
disease | 0.500 | None | 0.957 | 2 | 0 | 2005 | 2019 |